Forecasts by Product (Consumables, Equipment, Systems & Software), by Cell Type (T-Cells, Stem Cells, Other Cells), by Process (Cell Processing, Cell Preservation, Distribution, and Handling, Process Monitoring and Quality Control), End-user (Biopharmaceutical & Biotechnology Companies and CROs, Research Institutes and Cell Banks) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cell Therapy Technologies Companies AND COVID-19 Recovery Scenarios
Growing Focus on Precision Medicine to Offer Lucrative Growth Opportunities Over the Next Decade Cell therapy technologies are used across various research areas including gene therapy, cancer vaccines, regenerative medicine, biologics and others. Increasing global disease burden and the need for more personalized & precision medicine has led to massive growth in the cell therapy technologies market, which is likely to increase over the next decade. While the global market will experience significant growth, the Asia Pacific region is expected to be the fastest growing submarket, primarily due to the presence of large numbers of clinical research organizations (CROs) in the region.
Technological Advancements Anticipated to Fuel Cell Therapy Technologies Market Cell therapy technology is one of the fastest growing markets and is an ever-changing landscape. It represents the umbrella of recent advancement in the field of gene therapy, drug delivery, cancer vaccines, various application of stem cells, regenerative medicine, and tissue engineering. Higher government investments for cell-based research, availability of advanced cell therapy technologies and growing demand of cell therapies are expected to further propel the market growth.
UNIQUE COVID-19 VARIATIONS– only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 affects the economy.
Which Factors are Fueling Cell Therapy Technologies Industry Growth? • Rising incidence of chronic & infectious diseases • Large number of oncology-related cell therapy clinical trials • Increasing GMP certifications for cell therapy production facilities • Rising government initiatives towards cell-based research activities
Which Factors are Restraining Growth? • Dearth of skilled professionals • High cost of cell-based research & low success rate
What are the Market Opportunities? • Increasing public-private partnerships for the development of cell therapies • Emergence of iPSCs as an alternative to ESCs • Emerging economies across Asia Pacific region
How do prominent players strengthen their position throughout the world? You must read this newly updated report if you are involved in this sector. The report from Visiongain shows you potential revenues up to 2031, evaluate information, trends, opportunities and business outlooks.
Discover how to stay ahead Our 310+ page report provides 310+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Cell Therapy Technologies Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, Porter’s Analysis, product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Product • Consumables • Equipment • Systems & Software
Cell Type • T-Cells • Stem Cells • Other Cells
Process • Cell Processing • Cell Preservation, Distribution, and Handling • Process Monitoring and Quality Control
End-User • Biopharmaceutical & Biotechnology Companies • CROs, Research Institutes and Cell Banks
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 14 leading national markets:
By Region
• North America – U.S. – Canada
• Europe – Germany – UK – France – Italy – Spain – Rest of Europe
• Asia Pacific – China – Japan – India – Australia – Rest of Asia Pacific
• Rest of the World – Brazil – Mexico – GCC – Rest of RoW
Leading companies and the potential for market growth Overall world revenue for Cell Therapy Technologies Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which regions hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
Prospects for established firms and those seeking to enter the market– including company profiles for 12 of the major companies involved in the Cell Therapy Technologies Market. Some of the companies profiled in this report include Thermo Fisher Scientific, Merck KGaA, Lonza, Danaher, STEMCELL Technologies Inc., Sartorius AG, TERUMO BCT, INC., Fresenius Medical Care AG & Co. KGaA, Avantor, Inc., BD, CellGenix GmbH, and Sirion-Biotech GmbH.
Key Questions Answered by this Report: • What is the current size of the overall global cell therapy technologies market? How much will this market be worth from 2021 to 2031? • What are the main drivers and restraints that will shape the overall Cell Therapy Technologies market over the next ten years? • What are the main segments within the overall cell therapy technologies market? How much will each of these segments be worth for the period 2021 to 2031? How will the composition of the market change during that time, and why? • What factors will affect that industry and market over the next ten years? • What are the largest national markets for the world cell therapy technologies? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2031? • How will market shares of the leading national markets change by 2031, and which geographical region will lead the market in 2031? • Which are the leading companies and what are their activities, results, developments, and prospects? • What are the main trends that will affect the world cell therapy technologies market between 2021 and 2031? • What are the main strengths, weaknesses, opportunities, and threats for the market? • How will the global cell therapy technologies market evolve over the forecasted period, 2021 to 2031? • How will market shares of prominent national markets change from 2021, and which countries will lead the market in 2031, achieving highest revenues and fastest growth?
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is intended for everybody needing commercial analyses for the Global Cell Therapy Technologies Market and leading companies. You will find data, trends and predictions.
Buy our report today Cell Therapy Technologies Market Report 2021-2031: Forecasts by Product (Consumables, Equipment, Systems & Software), by Cell Type (T-Cells, Stem Cells, Other Cells), by Process (Cell Processing, Cell Preservation, Distribution, and Handling, Process Monitoring and Quality Control), End-user (Biopharmaceutical & Biotechnology Companies and CROs, Research Institutes and Cell Banks) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cell Therapy Technologies Companies AND COVID-19 Recovery Scenarios . Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview 1.1 Introduction to Cell Therapy Technologies Market 1.2 Cell Therapy Technologies Market Definition 1.3 Why You Should Read This Report 1.4 What This Report Delivers 1.5 Key Questions Answered By This Analytical Report Include: 1.6 Who is This Report For? 1.7 Methodology 1.7.1 COVID-19 Impact: Recovery Scenarios 1.7.2 Market Evaluation & Forecasting Methodology 1.8 Frequently Asked Questions (FAQs) 1.9 Associated Visiongain Reports 1.10 About Visiongain
2 Executive Summary
3 Industry Insights 3.1 Drivers 3.1.1 Rising incidence of chronic and infectious diseases 3.1.2 Large number of oncology-related cell therapy clinical trials 3.1.3 Increasing GMP certifications for cell therapy production facilities 3.2 Restraints 3.2.1 High cost of cell-based research and low success rate 3.2.2 Dearth of skilled professionals 3.3 Opportunities 3.3.1 Increasing public-private partnerships for the development of cell therapies 3.3.2 Emerging economies across Asia Pacific 3.3.3 Emergence of iPSCs as an alternative to ESCs 3.4 SWOT Analysis 3.4.1 Strengths 3.4.2 Weaknesses 3.4.3 Opportunities 3.4.4 Threats 3.5 Industry analysis - Porter’s 3.5.1 Buyer Power (Moderate-to-High) 3.5.2 Supplier Power 3.5.3 Competitive Rivalry 3.5.4 Threat of Substitute 3.5.5 Threat of New Entrants 3.6 Industry analysis – PEST Analysis 3.6.1 Political 3.6.2 Economical 3.6.3 Social 3.6.4 Technological
4 Cell Therapy Technologies Market by Product,2021-2031 4.1 Consumables Segment Market Forecast, 2021-2031 4.1.1 Recovery Scenarios (V, U, W, L) 4.2 Equipment Segment Market Forecast, 2021-2031 4.2.1 Recovery Scenarios (V, U, W, L) 4.3 Systems & Software Segment Market Forecast, 2021-2031 4.3.1 Recovery Scenarios (V, U, W, L)
5 Cell Therapy Technologies Market by Cell Type,2021-2031 5.1 T-Cells Segment Market Forecast, 2021-2031 5.1.1 Recovery Scenarios (V, U, W, L) 5.2 Stem Cells Segment Market Forecast, 2021-2031 5.2.1 Recovery Scenarios (V, U, W, L) 5.3 Other Cells Segment Market Forecast, 2021-2031 5.3.1 Recovery Scenarios (V, U, W, L)
6 Cell Therapy Technologies Market by Process,2021-2031 6.1 Cell Processing Segment Market Forecast, 2021-2031 6.1.1 Recovery Scenarios (V, U, W, L) 6.2 Cell Preservation, Distribution, and Handling Segment Market Forecast, 2021-2031 6.2.1 Recovery Scenarios (V, U, W, L) 6.3 Process Monitoring and Quality Control Segment Market Forecast, 2021-2031 6.3.1 Recovery Scenarios (V, U, W, L)
7 Cell Therapy Technologies Market by End-User 7.1 Biopharmaceutical & Biotechnology Companies and CROs Segment Market Forecast, 2021-2031 7.1.1 Recovery Scenarios (V, U, W, L) 7.2 Research Institutes and Cell Banks Segment Market Forecast, 2021-2031 7.2.1 Recovery Scenarios (V, U, W, L)
8 Regional and Leading National Cell Therapy Technologies Market Forecasts 2021-2031 8.1 Global Cell Therapy Technologies Market by Region Forecast 2021-2031 8.2 Recovery Scenarios (V, U, W, L)
9 North America Cell Therapy Technologies Market 9.1 North America Currently Dominates the Global Cell Therapy Technologies Market 9.2 North America Cell Therapy Technologies Market by Country, Forecast 2021-2031 9.3 North America Cell Therapy Technologies Market Forecast by Product 9.4 North America Cell Therapy Technologies Market Forecast by Cell Type 9.5 North America Cell Therapy Technologies Market Forecast by Process 9.6 North America Cell Therapy Technologies Market Forecast by End-User 9.7 U.S. Cell Therapy Technologies Market Forecast, 2021-2031 9.7.1 U.S. Dominates the North American Cell Therapy Technologies Market 9.7.2 Recovery Scenarios (V, U, W, L): U.S. Cell Therapy Technologies Market Forecast, 2021-2031 9.8 Canada Cell Therapy Technologies Market Forecast, 2021-2031 9.8.1 Growing Partnerships Among Research Entities to Fuel Regional Growth Through 2031 9.8.2 Recovery Scenarios (V, U, W, L): Canada Cell Therapy Technologies Market Forecast, 2021-2031
10 Europe Cell Therapy Technologies Market 10.1 Europe is Second Largest Cell Therapy Technologies Market Globally 10.2 Europe Cell Therapy Technologies Market by Country, Forecast 2021-2031 10.3 Europe Cell Therapy Technologies Market Forecast by Product 10.4 Europe Cell Therapy Technologies Market Forecast by Cell Type 10.5 Europe Cell Therapy Technologies Market Forecast by Process 10.6 Europe Cell Therapy Technologies Market Forecast by End-User 10.7 Germany Cell Therapy Technologies Market Forecast, 2021-2031 10.7.1 Germany Cell Therapy Technologies to Witness Highest Growth Across the European Region 10.7.2 Recovery Scenarios (V, U, W, L): Germany Cell Therapy Technologies Market Forecast, 2021-2031 10.8 UK Cell Therapy Technologies Market Forecast, 2021-2031 10.8.1 Collaborations Among Research Institutes to Boost UK Cell Therapy Technologies Market Growth 10.8.2 Recovery Scenarios (V, U, W, L): UK Cell Therapy Technologies Market Forecast, 2021-2031 10.9 France Cell Therapy Technologies Market Forecast, 2021-2031 10.9.1 French Cell Therapy Technologies Industry Anticipated to Offer Competitive Therapies Over the Next Decade 10.9.2 Recovery Scenarios (V, U, W, L): France Cell Therapy Technologies Market Forecast, 2021-2031 10.10 Italy Cell Therapy Technologies Market Forecast, 2021-2031 10.10.1 Support from Biomedical Institutions to Fuel Italian Cell Therapy Technologies Market 10.10.2 Recovery Scenarios (V, U, W, L): Italy Cell Therapy Technologies Market Forecast, 2021-2031 10.11 Spain Cell Therapy Technologies Market Forecast, 2021-2031 10.11.1 Spanish Cell Therapy Technologies Accounts for Significant Share Across the European Region 10.11.2 Recovery Scenarios (V, U, W, L): Spain Cell Therapy Technologies Market Forecast, 2021-2031 10.12 Rest of Europe Cell Therapy Technologies Market Forecast, 2021-2031 10.12.1 Recovery Scenarios (V, U, W, L): Rest of Europe Cell Therapy Technologies Market Forecast, 2021-2031
11 Asia Pacific Cell Therapy Technologies Market 11.1 Asia Pacific Cell Therapy Technologies to Witness Highest Growth Rate from 2021 to 2031 11.2 Asia Pacific Cell Therapy Technologies Market by Country, Forecast 2021-2031 11.3 Asia Pacific Cell Therapy Technologies Market Forecast by Product 11.4 Asia Pacific Cell Therapy Technologies Market Forecast by Cell Type 11.5 Asia Pacific Cell Therapy Technologies Market Forecast by Process 11.6 Asia Pacific Cell Therapy Technologies Market Forecast by End-User 11.7 Japan Cell Therapy Technologies Market Forecast, 2021-2031 11.7.1 Japanese Cell Therapy Technologies is Second Largest Market in Asia Pacific Region 11.7.2 Recovery Scenarios (V, U, W, L): Japan Cell Therapy Technologies Market Forecast, 2021-2031 11.8 China Cell Therapy Technologies Market Forecast, 2021-2031 11.8.1 China Currently Dominates the Asia Pacific Cell Therapy Technologies Market 11.8.2 Recovery Scenarios (V, U, W, L): China Cell Therapy Technologies Market Forecast, 2021-2031 11.9 India Cell Therapy Technologies Market Forecast, 2021-2031 11.9.1 Indian Cell Therapy Technologies Anticipated to Witness Highest Growth Rate from 2021 to 2031 11.9.2 Recovery Scenarios (V, U, W, L): India Cell Therapy Technologies Market Forecast, 2021-2031 11.10 Australia Cell Therapy Technologies Market Forecast, 2021-2031 11.10.1 Developing Global Capabilities Will Accelerate Regional Cell Therapy Technologies by 2031 11.10.2 Recovery Scenarios (V, U, W, L): Australia Cell Therapy Technologies Market Forecast, 2021-2031 11.11 Rest of Asia Pacific Cell Therapy Technologies Market Forecast, 2021-2031 11.11.1 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Cell Therapy Technologies Market Forecast, 2021-2031
12 RoW Cell Therapy Technologies Market 12.1 RoW Cell Therapy Technologies Market Being Driven by Brazilian Economy 12.2 Recovery Scenarios (V, U, W, L) 12.3 RoW Cell Therapy Technologies Market Forecast by Product 12.4 RoW Cell Therapy Technologies Market Forecast by Cell Type 12.5 RoW Cell Therapy Technologies Market Forecast by Process 12.6 RoW Cell Therapy Technologies Market Forecast by End-User 12.7 Brazil Cell Therapy Technologies Market Forecast, 2021-2031 12.7.1 Brazil Currently Dominates the RoW Cell Therapy Technologies Market 12.7.2 Recovery Scenarios (V, U, W, L): Brazil Cell Therapy Technologies Market Forecast, 2021-2031 12.8 Mexico Cell Therapy Technologies Market Forecast, 2021-2031 12.8.1 Mexican Cell Therapy Technologies to Offer Lucrative Growth Opportunities Through 2031 12.8.2 Recovery Scenarios (V, U, W, L): Mexico Cell Therapy Technologies Market Forecast, 2021-2031 12.9 GCC Cell Therapy Technologies Market Forecast, 2021-2031 12.9.1 Growing Research & Development to Fuel GCC Cell Therapy Technologies Market 12.9.2 Recovery Scenarios (V, U, W, L): GCC Cell Therapy Technologies Market Forecast, 2021-2031 12.10 Rest of RoW Cell Therapy Technologies Market Forecast, 2021-2031 12.10.1 Recovery Scenarios (V, U, W, L): Rest of RoW Cell Therapy Technologies Market Forecast, 2021-2031
13 Company Profiles 13.1 Thermo Fisher Scientific 13.1.1 Company Snapshot 13.1.2 Company Overview 13.1.3 Financial Analysis, 2015-2019 13.1.4 Product Benchmarking 13.1.5 Recent Developments 13.2 Merck KGaA 13.2.1 Company Snapshot 13.2.2 Company Overview 13.2.3 First Company to Make Acoustic Technology Available for Cell Therapy Manufacturing 13.2.4 Financial Analysis, 2015-2019 13.2.5 Product Benchmarking 13.2.6 Recent Developments 13.3 Lonza 13.3.1 Company Snapshot 13.3.2 Company Overview 13.3.3 Manufacturing Agreement: Mesoblast and Lonza 13.3.4 Financial Analysis, 2015-2019 13.3.5 Product Benchmarking 13.3.6 Recent Developments 13.4 Danaher 13.4.1 Company Snapshot 13.4.2 Company Overview 13.4.3 Financial Analysis, 2015-2019 13.4.4 Product Benchmarking 13.5 STEMCELL Technologies Inc. 13.5.1 Company Snapshot 13.5.2 Company Overview 13.5.3 Product Benchmarking 13.6 Sartorius AG 13.6.1 Company Snapshot 13.6.2 Company Overview 13.6.3 Financial Analysis, 2015-2019 13.6.4 Product Benchmarking 13.6.5 Recent Developments 13.7 TERUMO BCT, INC. 13.7.1 Company Snapshot 13.7.2 Company Overview 13.7.3 Financial Analysis, 2015-2019 13.7.4 Product Benchmarking 13.7.5 Recent Developments 13.8 Fresenius Medical Care AG & Co. KGaA 13.8.1 Company Snapshot 13.8.2 Company Overview 13.8.3 Financial Analysis, 2015-2019 13.8.4 Product Benchmarking 13.8.5 Recent Developments 13.9 Avantor, Inc. 13.9.1 Company Snapshot 13.9.2 Company Overview 13.9.3 Financial Analysis 13.9.4 Services Benchmarking 13.9.5 Recent Developments 13.10 BD 13.10.1 Company Snapshot 13.10.2 Company Overview 13.10.3 Financial Analysis, 2015-2019 13.10.4 Product Benchmarking 13.10.5 Recent Developments 13.11 CellGenix GmbH 13.11.1 Company Snapshot 13.11.2 Company Overview 13.11.3 Recent Developments 13.12 Sirion-Biotech GmbH 13.12.1 Company Snapshot 13.12.2 Company Overview 13.12.3 Product Benchmarking 13.12.4 Recent Developments
14 Conclusion 14.1 Concluding Remarks 14.2 Recommendations for Market Players 14.3 Asia Pacific Cell Therapy Technologies Anticipated to Offer Lucrative Growth Opportunities Through 2031
List of Figures Figure 1 Global Cell Therapy Technologies Market: Market Segmentation Figure 2 Global Cell Therapy Technologies Market: Market Dynamics Figure 3 Global Cell Therapy Technologies Market: SWOT Analysis Figure 4 Porter’s Analysis Figure 5 PEST Analysis Figure 6 Global Cell Therapy Technologies Market Forecast by Product, 2021-2031 (US$ million, AGR %) Figure 7 Global Cell Therapy Technologies Market Share Forecast by Product, 2021, 2026, 2031 (%) Figure 8 Global Cell Therapy Technologies Market for Consumables Segment: Revenue Forecast 2021-2031 (US$ million, AGR%) Figure 9 Global Cell Therapy Technologies Market for Consumables Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 10 Global Cell Therapy Technologies Market for Consumables Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 11 Global Cell Therapy Technologies Market for Consumables Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 12 Global Cell Therapy Technologies Market for Consumables Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 13 Global Cell Therapy Technologies Market for Equipment Segment: Revenue Forecast 2021-2031 (US$ million, AGR%) Figure 14 Global Cell Therapy Technologies Market for Equipment Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 15 Global Cell Therapy Technologies Market for Equipment Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 16 Global Cell Therapy Technologies Market for Equipment Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 17 Global Cell Therapy Technologies Market for Equipment Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 18 Global Cell Therapy Technologies Market for Systems & Software Segment: Revenue Forecast 2021-2031 (US$ million, AGR%) Figure 19 Global Cell Therapy Technologies Market for Systems & Software Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 20 Global Cell Therapy Technologies Market for Systems & Software Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 21 Global Cell Therapy Technologies Market for Systems & Software Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 22 Global Cell Therapy Technologies Market for Systems & Software Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 23 Global Cell Therapy Technologies Market Forecast by Cell Type, 2021-2031 (US$ million, AGR %) Figure 24 Global Cell Therapy Technologies Market Share Forecast by Cell Type, 2021, 2026, 2031 (%) Figure 25 Global Cell Therapy Technologies Market for T-Cells Segment: Revenue Forecast 2021-2031 (US$ million, AGR%) Figure 26 Global Cell Therapy Technologies Market for T-Cells Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 27 Global Cell Therapy Technologies Market for T-Cells Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 28 Global Cell Therapy Technologies Market for T-Cells Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 29 Global Cell Therapy Technologies Market for T-Cells Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 30 Global Cell Therapy Technologies Market for Stem Cells Segment: Revenue Forecast 2021-2031 (US$ million, AGR%) Figure 31 Global Cell Therapy Technologies Market for Stem Cells Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 32 Global Cell Therapy Technologies Market for Stem Cells Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 33 Global Cell Therapy Technologies Market for Stem Cells Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 34 Global Cell Therapy Technologies Market for Stem Cells Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 35 Global Cell Therapy Technologies Market for Other Cells Segment: Revenue Forecast 2021-2031 (US$ million, AGR%) Figure 36 Global Cell Therapy Technologies Market for Other Cells Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 37 Global Cell Therapy Technologies Market for Other Cells Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 38 Global Cell Therapy Technologies Market for Other Cells Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 39 Global Cell Therapy Technologies Market for Other Cells Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 40 Global Cell Therapy Technologies Market Forecast by Process, 2021-2031 (US$ million, AGR %) Figure 41 Global Cell Therapy Technologies Market Share Forecast by Process, 2021, 2026, 2031 (%) Figure 42 Global Cell Therapy Technologies Market for Cell Processing Segment: Revenue Forecast 2021-2031 (US$ million, AGR%) Figure 43 Global Cell Therapy Technologies Market for Cell Processing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 44 Global Cell Therapy Technologies Market for Cell Processing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 45 Global Cell Therapy Technologies Market for Cell Processing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 46 Global Cell Therapy Technologies Market for Cell Processing Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 47 Global Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling Segment: Revenue Forecast 2021-2031 (US$ million, AGR%) Figure 48 Global Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 49 Global Cell Therapy Technologies Market for Cell Preservation, Distribution, and Handling Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 50 Global Cell Therapy Technologies Market for Process Monitoring and Quality Control Segment: Revenue Forecast 2021-2031 (US$ million, AGR%) Figure 51 Global Cell Therapy Technologies Market for Process Monitoring and Quality Control Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 52 Global Cell Therapy Technologies Market for Process Monitoring and Quality Control Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 53 Global Cell Therapy Technologies Market for Process Monitoring and Quality Control Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 54 Global Cell Therapy Technologies Market for Process Monitoring and Quality Control Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 55 Global Cell Therapy Technologies Market Forecast by End-User, 2021-2031 (US$ million, AGR %) Figure 56 Global Cell Therapy Technologies Market Share Forecast by End-User, 2021, 2026, 2031 (%) Figure 57 Global Cell Therapy Technologies Market for Biopharmaceutical & Biotechnology Companies and CROs Segment: Revenue Forecast 2021-2031 (US$ million, AGR%) Figure 58 Global Cell Therapy Technologies Market for Biopharmaceutical & Biotechnology Companies and CROs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 59 Global Cell Therapy Technologies Market for Biopharmaceutical & Biotechnology Companies and CROs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 60 Global Cell Therapy Technologies Market for Biopharmaceutical & Biotechnology Companies and CROs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 61 Global Cell Therapy Technologies Market for Biopharmaceutical & Biotechnology Companies and CROs Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 62 Global Cell Therapy Technologies Market for Research Institutes and Cell Banks Segment: Revenue Forecast 2021-2031 (US$ million, AGR%) Figure 63 Global Cell Therapy Technologies Market for Research Institutes and Cell Banks Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 64 Global Cell Therapy Technologies Market for Research Institutes and Cell Banks Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 65 Global Cell Therapy Technologies Market for Research Institutes and Cell Banks Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 66 Global Cell Therapy Technologies Market for Research Institutes and Cell Banks Segment, Revenue Forecast 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 67 Global Cell Therapy Technologies Market Forecast by Region 2021-2031 (US$ million) Figure 68 Global Cell Therapy Technologies Market Share Forecast by Region 2021, 2026, 2031 (%) Figure 69 Global Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 70 Global Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 71 Global Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 72 Global Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 73 North America Cell Therapy Technologies Market Forecast by Country 2021-2031 (US$ million) Figure 74 North America Cell Therapy Technologies Market Share Forecast by Country 2021, 2026, 2031 (%) Figure 75 North America Cell Therapy Technologies Market Forecast by Product, 2021-2031 (US$ million, AGR%) Figure 76 North America Cell Therapy Technologies Market Forecast by Cell Type, 2021-2031 (US$ million, AGR%) Figure 77 North America Cell Therapy Technologies Market Forecast by Process, 2021-2031 (US$ million, AGR%) Figure 78 North America Cell Therapy Technologies Market Forecast by End-User, 2021-2031 (US$ million, AGR%) Figure 79 U.S. Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR %) Figure 80 U.S. Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 81 U.S. Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 82 U.S. Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 83 U.S. Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 84 Canada Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR %) Figure 85 Canada Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 86 Canada Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 87 Canada Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 88 Canada Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 89 Europe Cell Therapy Technologies Market Forecast by Country 2021-2031 (US$ million) Figure 90 Europe Cell Therapy Technologies Market Share Forecast by Country 2021, 2026, 2031 (%) Figure 91 Europe Cell Therapy Technologies Market Forecast by Product, 2021-2031 (US$ million, AGR%) Figure 92 Europe Cell Therapy Technologies Market Forecast by Cell Type, 2021-2031 (US$ million, AGR%) Figure 93 Europe Cell Therapy Technologies Market Forecast by Process, 2021-2031 (US$ million, AGR%) Figure 94 Europe Cell Therapy Technologies Market Forecast by End-User, 2021-2031 (US$ million, AGR%) Figure 95 Germany Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR %) Figure 96 Germany Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 97 Germany Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 98 Germany Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 99 Germany Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 100 UK Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR %) Figure 101 UK Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 102 UK Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 103 UK Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 104 UK Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 105 France Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR %) Figure 106 France Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 107 France Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 108 France Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 109 France Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 110 Italy Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR %) Figure 111 Italy Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 112 Italy Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 113 Italy Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 114 Italy Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 115 Spain Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR %) Figure 116 Spain Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 117 Spain Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 118 Spain Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 119 Spain Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 120 Rest of Europe Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR %) Figure 121 Rest of Europe Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 122 Rest of Europe Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 123 Rest of Europe Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 124 Rest of Europe Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 125 Asia Pacific Cell Therapy Technologies Market Forecast by Country 2021-2031 (US$ million) Figure 126 Asia Pacific Cell Therapy Technologies Market Share Forecast by Country 2021, 2026, 2031 (%) Figure 127 Asia Pacific Cell Therapy Technologies Market Forecast by Product, 2021-2031 (US$ million, AGR%) Figure 128 Asia Pacific Cell Therapy Technologies Market Forecast by Cell Type, 2021-2031 (US$ million, AGR%) Figure 129 Asia Pacific Cell Therapy Technologies Market Forecast by Process, 2021-2031 (US$ million, AGR%) Figure 130 Asia Pacific Cell Therapy Technologies Market Forecast by End-User, 2021-2031 (US$ million, AGR%) Figure 131 Japan Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR %) Figure 132 Japan Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 133 Japan Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 134 Japan Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 135 Japan Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 136 China Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR %) Figure 137 China Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 138 China Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 139 China Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 140 China Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 141 India Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR %) Figure 142 India Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 143 India Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 144 India Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 145 India Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 146 Australia Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR %) Figure 147 Australia Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 148 Australia Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 149 Australia Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 150 Australia Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 151 Rest of Asia Pacific Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR %) Figure 152 Rest of Asia Pacific Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 153 Rest of Asia Pacific Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 154 Rest of Asia Pacific Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 155 Rest of Asia Pacific Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 156 RoW Cell Therapy Technologies Market Forecast by Country 2021-2031 (US$ million) Figure 157 RoW Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 158 RoW Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 159 RoW Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 160 RoW Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 161 RoW Cell Therapy Technologies Market Forecast by Product, 2021-2031 (US$ million, AGR%) Figure 162 RoW Cell Therapy Technologies Market Forecast by Cell Type, 2021-2031 (US$ million, AGR%) Figure 163 RoW Cell Therapy Technologies Market Forecast by Process, 2021-2031 (US$ million, AGR%) Figure 164 RoW Cell Therapy Technologies Market Forecast by End-User, 2021-2031 (US$ million, AGR%) Figure 165 Brazil Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR %) Figure 166 Brazil Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 167 Brazil Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 168 Brazil Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 169 Brazil Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 170 Mexico Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR %) Figure 171 Mexico Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 172 Mexico Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 173 Mexico Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 174 Mexico Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 175 GCC Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR %) Figure 176 GCC Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 177 GCC Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 178 GCC Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 179 GCC Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 180 Rest of RoW Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR %) Figure 181 Rest of RoW Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “V” Shaped Recovery Figure 182 Rest of RoW Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “U” Shaped Recovery Figure 183 Rest of RoW Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “W” Shaped Recovery Figure 184 Rest of RoW Cell Therapy Technologies Market Forecast, 2021-2031 (US$ million, AGR%): “L” Shaped Recovery Figure 185 Thermo Fisher Scientific: Net Revenue, 2015-2019 (US$ million, AGR%) Figure 186 Merck KGaA: Net Revenue, 2015-2019 (US$ million, AGR%) Figure 187 Lonza: Net Revenue, 2015-2019 (US$ million, AGR%) Figure 188 Danaher: Net Revenue, 2015-2019 (US$ million, AGR%) Figure 189 Sartorius AG: Net Revenue, 2015-2019 (US$ million, AGR%) Figure 190 TERUMO BCT, INC.: Net Revenue, 2015-2019 (US$ million, AGR%) Figure 191 Fresenius Medical Care AG & Co. KGaA: Net Revenue, 2015-2019 (US$ million, AGR%) Figure 192 Avantor, Inc.: Net Revenue, 2015-2019 (US$ million, AGR%) Figure 193 BD: Net Revenue, 2015-2019 (US$ million, AGR%) Figure 194 Global Cell Therapy Technologies Market Forecast by Region 2021-2031 (US$ million)
Companies Profiled in the Report Avantor, Inc. BD CellGenix GmbH Danaher Fresenius Medical Care AG & Co. KGaA Lonza, Danaher Merck KGaA Sartorius AG Sirion-Biotech GmbH STEMCELL Technologies Inc. TERUMO BCT, INC. Thermo Fisher Scientific
List of Other Companies Abeona Therapeutics Acucela Adaptimmune Therapeutics Antapodia Nanotherapeutics Aruvant Sciences Autolus AveXis BioCancell Biomay Biomiga BioReliance Biotec Services International Biovian Celladon Cellatoz Therapeutics Cellectis Cellular Biomedicine Group Cytiva D&D PharmaTech Delphi Genetics Department of Neuroscience, University of Minnesota Desktop Genetics DNAtrix Elicio Therapeutics Elixirgen Scientific Epeius Biotechnologies EUFETS Eurofins Genomics European Society of Gene and Cell Therapy GEG Tech Genable Technologies Henlius Biotech Immune Design Immune Technology ImmunoGenes Immunomic Therapeutics Inbiomed Indiana University Vector Production Facility MiCAN Technologies Novadip Biosciences NovaGo Therapeutics Noveome Biotherapeutics Synplogen VIVEbiotech Voyager Therapeutics Waisman Biomanufacturing Xpress Biologics
List of Organizations Mentioned in the Report American Society of Gene and Cell Therapy (ASGCT) Australasian Gene and Cell Therapy Society (AGCTS) Austrian Network for Gene Therapy British Society of Gene and Cell Therapy (BSGCT) European Society of Gene and Cell Therapy (ESGCT) Finnish Gene Therapy Society (FGTS) Foundation for the Accreditation of Cellular Therapy (FACT) French Society of Cellular and Gene Therapy (SFTCG) German Gene Therapy Society (DGGT) International Society for Cell & Gene Therapy (ISCT) International Society for Stem Cells Applications (ISSCA) Israeli Society of Gene & Cell Therapy (ISGCT) Japan Society of Gene Therapy (JSGT) Korean Society of Gene and Cell Therapy (KSGCT) Malaysia Association for Cell Therapy (MACT) Netherlands Society of Gene and Cell Therapy (NVGCT) Pakistan Society of Gene and Cell Therapy (PSGCT) Spanish Society of Gene and Cell Therapy (SETGyC) Swedish Society for Gene and Cell Therapy (SSGCT) Turkish Society of Gene & Cell Therapy (TSGCT)
Download sample pages
Complete the form below to download your free sample pages for Cell Therapy Technologies Market Report 2021-2031
Over the last few years, the antisense oligonucleotide therapeutics has gained widespread attention due to the technological advancements and growth...
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033
The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.
Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033
The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.
Visiongain Publishes Contract Research Organisations (CROs) Market Report 2023-2033
The global Contract Research Organisations (CROs) market was valued at US$68.9 billion in 2023 and is projected to grow at a CAGR of 10.6% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
